Macrolide resistance mechanisms in Enterobacteriaceae: Focus on azithromycin
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Authors
Gomes, CláudiaMartínez Puchol, Sandra
Palma, Noemí
Horna, Gertrudis
Ruiz-Roldán, Lidia
Pons, Maria J
Ruiz, Joaquim
Issue Date
2016-10-27xmlui.metadata.dc.contributor.email
[email protected]
Metadata
Show full item recordCitation
1. Gomes C, Martínez-puchol S, Palma N, Horna G, Ruiz-roldán L, Pons MJ, et al. Critical Reviews in Microbiology Macrolide resistance mechanisms in Enterobacteriaceae : Focus on azithromycin Macrolide resistance mechanisms in Enterobacteriaceae : Focus on azithromycin. Crit Rev Microbiol [Internet]. Informa Healthcare USA, Inc; 2016;0(0):000. Available from: http://dx.doi.org/10.3109/1040841X.2015.1136261Publisher
Taylor & FrancisJournal
Critical Reviews in MicrobiologyDOI
10.3109/1040841X.2015.1136261Additional Links
https://www.tandfonline.com/doi/full/10.3109/1040841X.2015.1136261Abstract
From its introduction in 1952 onwards, the clinical use of macrolides has been steadily increasing, both in human and veterinary medicine. Although initially designed to the treatment of Grampositive microorganisms, this antimicrobial family has also been used to treat specific Gram-negative bacteria. Some of them, as azithromycin, are considered in the armamentarium against Enterobacteriaceae infections. However, the facility that this bacterial genus has to gain or develop mechanisms of antibiotic resistance may compromise the future usefulness of these antibiotics to fight against Enterobacteriaceae infections. The present review is focused on the mechanisms of macrolide resistance, currently described in Enterobacteriaceae.Type
info:eu-repo/semantics/articleRights
info:eu-repo/semantics/openAccessLanguage
engISSN
1040-841X1549-7828
Sponsors
CG has a PhD fellowship of the ISCIII [grant number: FI12/ 00561]. GH has a PhD fellowship from the Schlumberger Foundation – Faculty for The Future Program. LR-R has a PhD fellowship from Sistema Riojano de Innovaci on del Gobierno de La Rioja. MJP has a postdoctoral fellowship from CONCYTEC [grant number: CG05-2013-FONDECYT]. JR has a fellowship from the program I3, of the ISCIII [grant number: CES11/012]. The study was supported by the Generalitat de Catalunya, Departament d’Universitats, Recerca i Societat de la Informaci o [2014 SGR 26] and by the Spanish Network for the Research in Infectious Diseases [REIPI RD12/0015].ae974a485f413a2113503eed53cd6c53
10.3109/1040841X.2015.1136261
Scopus Count
Collections